D Adeloye1, D Q Abaa2, E O Owolabi3, B M Ale4, R G Mpazanje5, M T Dewan5, C Omoyele6, N Ezeigwe6, W Alemu7, M O Harhay8, A Auta9, I F Adewole10. 1. Centre for Global Health, Usher Institute, University of Edinburgh, UK; RcDavies Evidence-based Medicine, Lagos, Nigeria. Electronic address: Davies.Adeloye@ed.ac.uk. 2. Solina Centre for International Development and Research (SCIDaR), Abuja, Nigeria. 3. Department of Nursing Sciences, University of Fort Hare, East London, South Africa. 4. INSERM UMR 1219, Bordeaux Population Health Research Center, Bordeaux, France; Holo Healthcare Limited, Nairobi, Kenya. 5. WHO Nigeria Country Office, Abuja, Nigeria. 6. Federal Ministry of Health, Abuja, Nigeria. 7. International Health Consultancy, LLC, Atlanta, Georgia, USA. 8. Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine University of Pennsylvania Philadelphia, Pennsylvania, USA; Palliative and Advanced Illness Research (PAIR) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 9. School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Fylde Road, Preston, UK. 10. College of Medicine, University of Ibadan, Ibadan, Nigeria.
Abstract
OBJECTIVES: Elevated blood cholesterol (hypercholesterolemia) is a significant cause of cardiovascular disease. We aimed to estimate national and zonal prevalence of hypercholesterolemia in Nigeria to help guide targeted public health programs. STUDY DESIGN: This is a systematic review and synthesis of publicly available epidemiologic data on hypercholesterolemia in Nigeria. METHODS: We systematically searched MEDLINE, EMBASE, Global Health, and Africa Journals Online for studies on the prevalence of hypercholesterolemia in Nigeria published between 1990 and 2018. We used a random-effects meta-analysis (Freeman-Tukey double arcsine transformation) and meta-regression model to estimate the prevalence of hypercholesterolemia in Nigeria in 1995 and 2015. RESULTS: In total, 13 studies (n = 16,981) were retrieved. The pooled crude prevalence of hypercholesterolemia in Nigeria was 38% (95% confidence interval: 26-51), with prevalence in women slightly higher (42%, 23-63) compared with men (38%, 20-58). The prevalence was highest in the South-south (53%, 38-68) and lowest in the South-west (3%, 2-4) and North-east (4%, 2-7). Urban dwellers had a significantly higher rate (52%, 24-79) compared with rural dwellers (10%, 6-15). We estimated over 8.2 million persons (age-adjusted prevalence 16.5%) aged 20 years or more had hypercholesterolemia in Nigeria in 1995, increasing to 21.9 million persons (age-adjusted prevalence 25.9%) in 2015. CONCLUSIONS: Our findings suggest a high prevalence of hypercholesterolemia in Nigeria. Urbanization, lifestyles, diets, and culture appear to be driving an increasing prevalence, especially among women. Population-wide awareness and education on reducing elevated cholesterol levels and associated risks should be prioritized.
OBJECTIVES: Elevated blood cholesterol (hypercholesterolemia) is a significant cause of cardiovascular disease. We aimed to estimate national and zonal prevalence of hypercholesterolemia in Nigeria to help guide targeted public health programs. STUDY DESIGN: This is a systematic review and synthesis of publicly available epidemiologic data on hypercholesterolemia in Nigeria. METHODS: We systematically searched MEDLINE, EMBASE, Global Health, and Africa Journals Online for studies on the prevalence of hypercholesterolemia in Nigeria published between 1990 and 2018. We used a random-effects meta-analysis (Freeman-Tukey double arcsine transformation) and meta-regression model to estimate the prevalence of hypercholesterolemia in Nigeria in 1995 and 2015. RESULTS: In total, 13 studies (n = 16,981) were retrieved. The pooled crude prevalence of hypercholesterolemia in Nigeria was 38% (95% confidence interval: 26-51), with prevalence in women slightly higher (42%, 23-63) compared with men (38%, 20-58). The prevalence was highest in the South-south (53%, 38-68) and lowest in the South-west (3%, 2-4) and North-east (4%, 2-7). Urban dwellers had a significantly higher rate (52%, 24-79) compared with rural dwellers (10%, 6-15). We estimated over 8.2 million persons (age-adjusted prevalence 16.5%) aged 20 years or more had hypercholesterolemia in Nigeria in 1995, increasing to 21.9 million persons (age-adjusted prevalence 25.9%) in 2015. CONCLUSIONS: Our findings suggest a high prevalence of hypercholesterolemia in Nigeria. Urbanization, lifestyles, diets, and culture appear to be driving an increasing prevalence, especially among women. Population-wide awareness and education on reducing elevated cholesterol levels and associated risks should be prioritized.
Authors: Madhukar Pai; Michael McCulloch; Jennifer D Gorman; Nitika Pai; Wayne Enanoria; Gail Kennedy; Prathap Tharyan; John M Colford Journal: Natl Med J India Date: 2004 Mar-Apr Impact factor: 0.537
Authors: Lakshmi Venkitachalam; Kaijun Wang; Avi Porath; Ramon Corbalan; Alan T Hirsch; David J Cohen; Sidney C Smith; E Magnus Ohman; Ph Gabriel Steg; Deepak L Bhatt; Elizabeth A Magnuson Journal: Circulation Date: 2012-04-09 Impact factor: 29.690
Authors: Davies Adeloye; Adebanke Olawole-Isaac; Asa Auta; Mary T Dewan; Chiamaka Omoyele; Nnenna Ezeigwe; Wura Jacobs; Rex G Mpazanje; Michael O Harhay; Wondimagegnehu Alemu; Isaac F Adewole Journal: Am J Drug Alcohol Abuse Date: 2019-06-27 Impact factor: 3.829
Authors: Rhonda BeLue; Titilayo A Okoror; Juliet Iwelunmor; Kelly D Taylor; Arnold N Degboe; Charles Agyemang; Gbenga Ogedegbe Journal: Global Health Date: 2009-09-22 Impact factor: 4.185
Authors: Davies Adeloye; Asa Auta; Ademola Fawibe; Muktar Gadanya; Nnenna Ezeigwe; Rex G Mpazanje; Mary T Dewan; Chiamaka Omoyele; Wondimagegnehu Alemu; Michael O Harhay; Isaac F Adewole Journal: BMC Public Health Date: 2019-12-21 Impact factor: 3.295